AMPK mediates energetic stress‐induced liver GDF15
Open Access
- 18 December 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 35 (1) , e21218
Abstract
Growth differentiating factor‐15 (GDF15) is an emerging target for the treatment of obesity and metabolic disease partly due to its ability to suppress food intake. GDF15 expression and secretion are thought to be regulated by a cellular integrated stress response, which involves endoplasmic reticulum (ER) stress. AMPK is another cellular stress sensor, but the relationship between AMPK, ER stress, and GDF15 has not been assessed in vivo. Wildtype (WT), AMPK β1 deficient (AMPKβ1 −/− ), and CHOP −/− mice were treated with three distinct AMPK activators; AICAR, which is converted to ZMP mimicking the effects of AMP on the AMPKγ isoform, R419, which indirectly activates AMPK through inhibition of mitochondrial respiration, or A769662, a direct AMPK activator which binds the AMPKβ1 isoform ADaM site causing allosteric activation. Following treatments, liver Gdf15 , markers of ER‐stress, AMPK activity, adenine nucleotides, circulating GDF15, and food intake were assessed. AICAR and R419 caused ER and energetic stress, increased GDF15 expression and secretion, and suppressed food intake. Direct activation of AMPK β1 containing complexes by A769662 increased hepatic Gdf15 expression, circulating GDF15, and suppressed food intake, independent of ER stress. The effects of AICAR, R419, and A769662 on GDF15 were attenuated in AMPKβ1 −/− mice. AICAR and A769662 increased GDF15 to a similar extent in WT and CHOP −/− mice. Herein, we provide evidence that AMPK plays a role in mediating the induction of GDF15 under conditions of energetic stress in mouse liver in vivo.Keywords
Funding Information
- Canadian Institutes of Health Research
This publication has 64 references indexed in Scilit:
- Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liverJournal of Lipid Research, 2012
- Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesityJournal of Clinical Investigation, 2011
- AMPK Is a Direct Adenylate Charge-Regulated Protein KinaseScience, 2011
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJournal of Clinical Investigation, 2010
- Assessment of Feeding Behavior in Laboratory MiceCell Metabolism, 2010
- Reversible Ponceau staining as a loading control alternative to actin in Western blotsAnalytical Biochemistry, 2010
- AMPK β1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin ResistanceJournal of Biological Chemistry, 2010
- AMPK in Health and DiseasePhysiological Reviews, 2009
- AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA ribosideBiochemical Journal, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001